Lv46
500 积分 2023-12-01 加入
科研通真好用！爱了爱了
A proposal from the Liver Forum for the management of comorbidities in nonalcoholic steatohepatitis therapeutic trials
1个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Determination of Two Potential Genotoxic Impurities in Crisaborole API by UPLC-MS/MS
2个月前
已完结
Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges
2个月前
已完结
Discovery of a Macrocyclic Influenza Cap-Dependent Endonuclease Inhibitor
2个月前
已完结
Mutual Prodrugs - Codrugs
4个月前
已完结
皖公网安备34019202002308
